Skip to main content
Premium Trial:

Request an Annual Quote

InphoGene Uses GeneChip To Build Online Databases

Premium

VANCOUVER, BC--InphoGene BioCom, a genomics and bioinformatics company here, said it would use Affymetrix's GeneChip to build a series of databases of gene expression information relating to cardiopulmonary disease. The company said it has access to human heart, blood vessel, and lung tissue that will enable it to build internet-based gene expression databases that will be major commercial reference sources for cardiopulmonary disease information. InphoGene will market the databases to pharmaceutical and biotechnology companies, for use alone or in combination with Affymetrix GeneChip probe arrays.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.